Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

May 31, 2022


Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
Intest Res. 2022;20(4):392-417.

Review

December 2, 2021


Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intest Res. 2022;20(4):418-430.

Statement

January 5, 2022


Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, et al.
Intest Res. 2022;20(4):431-444.

Original Article

February 8, 2022


Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, et al.
Intest Res. 2022;20(4):445-451.

Original Article

March 11, 2022


Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, et al.
Intest Res. 2022;20(4):452-463.

Original Article

March 31, 2022


Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
Intest Res. 2022;20(4):464-474.

Original Article

June 13, 2022


Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, et al.
Intest Res. 2022;20(4):475-481.

Original Article

April 15, 2022


Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, et al.
Intest Res. 2022;20(4):482-494.

Original Article

August 8, 2022


Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, et al.
Intest Res. 2022;20(4):495-505.

Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models
Emiko Mizoguchi, Daren Low, Yui Ezaki, et al.
Intest Res. 2020;18(2):151-167.

Review

Epub April 20, 2020

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
Hyung-Hoon Oh, Young-Eun Joo
Intest Res. 2020;18(2):168-183.

Review

Epub November 30, 2019

Fibrostenotic strictures in Crohn’s disease
Jun Hwan Yoo, Stefan Holubar, Florian Rieder
Intest Res. 2020;18(4):379-401.

Review

Epub April 10, 2020

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases
Jung Min Kim, Jae Hee Cheon
Intest Res. 2020;18(3):249-264.

Review

Epub April 18, 2020

Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study
Jamilya Kaibullayeva, Aliya Ualiyeva, Ainash Oshibayeva, et al.
Intest Res. 2020;18(4):430-437.

Original Article

Epub September 29, 2020

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, et al.
Intest Res. 2020;18(1):79-84.

Original Article

Epub January 30, 2020

Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases
Julajak Limsrivilai, Nonthalee Pausawasdi
Intest Res. 2021;19(1):21-32.

Review

Epub April 22, 2020

Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, et al.
Intest Res. 2022;20(1):11-30.

Review

Epub April 15, 2021

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
Katsuyoshi Matsuoka
Intest Res. 2020;18(3):275-281.

Review

Epub June 3, 2020

Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation
Young Sook Park, Soo Hyung Kim, Jong Won Park, et al.
Intest Res. 2020;18(3):325-336.

Original Article

Epub June 23, 2020

Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
Kenji Watanabe
Intest Res. 2020;18(4):347-354.

Review

Epub October 26, 2020

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, et al.
Intest Res. 2020;18(1):18-33.

Review

Epub January 30, 2020

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
Sang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Intest Res. 2020;18(1):34-44.

Review

Epub January 30, 2020

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
Antigony Mitselou, Vasileios Grammeniatis, Anna Varouktsi, et al.
Intest Res. 2020;18(1):115-120.

Original Article

Epub January 30, 2020

Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
Shin Ju Oh, Ga Young Shin, Hosim Soh, et al.
Intest Res. 2021;19(3):323-331.

Original Article

Epub August 18, 2020

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, et al.
Intest Res. 2021;19(1):71-82.

Original Article

Epub September 4, 2020

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
Shinta Mizuno, Keiko Ono, Yohei Mikami, et al.
Intest Res. 2020;18(1):69-78.

Original Article

Epub January 30, 2020

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, et al.
Intest Res. 2021;19(1):62-70.

Original Article

Epub May 8, 2020

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit Sood, Kirandeep Kaur, Ramit Mahajan, et al.
Intest Res. 2021;19(2):206-216.

Original Article

Epub July 13, 2020

Management of inflammatory bowel disease in the COVID-19 era
Kyeong Ok Kim, Byung Ik Jang
Intest Res. 2022;20(1):3-10.

Review

Epub February 3, 2021

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
Toshifumi Hibi, Isao Kamae, Philippe Pinton, et al.
Intest Res. 2021;19(1):53-61.

Original Article

Epub April 22, 2020

Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intest Res. 2022;20(4):418-430.

Review

Epub December 2, 2021

Update of endoscopic management of Crohn’s disease strictures
Akshay Pokala, Bo Shen
Intest Res. 2020;18(1):1-10.

Review

Epub January 30, 2020

Quality of life in inflammatory bowel diseases: it is not all about the bowel
Ronald Keller, Nazar Mazurak, Laura Fantasia, et al.
Intest Res. 2021;19(1):45-52.

Original Article

Epub February 27, 2020

Differentiation of fibrotic and inflammatory component of Crohn’s disease-associated strictures
Jordi Rimola, Nunzia Capozzi
Intest Res. 2020;18(2):144-150.

Review

Epub April 20, 2020

Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Ashish Agarwal, Alka Singh, Wajiha Mehtab, et al.
Intest Res. 2021;19(1):106-114.

Original Article

Epub April 22, 2020

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, et al.
Intest Res. 2021;19(1):95-105.

Original Article

Epub July 10, 2020

Management of Clostridioides difficile infection in patients with inflammatory bowel disease
Sahil Khanna
Intest Res. 2021;19(3):265-274.

Review

Epub August 18, 2020

Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
Katsuhiro Arai, Reiko Kunisaki, Fumihiko Kakuta, et al.
Intest Res. 2020;18(4):412-420.

Original Article

Epub August 18, 2020

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, et al.
Intest Res. 2021;19(4):419-429.

Original Article

Epub November 10, 2020

  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next